[Neurogenic inflammation in nasal hyperreactivity].
The role of neuropeptides in nasal hyperreactivity was examined in guinea pigs by histochemical and pharmacological study. Intranasal application of toluene diisocynate (TDI) induced nasal hyperreactivity symptoms: sneezing and watery rhinorrhea, and decreased histamine content in the nasal mucosa in guinea pigs sensitized with TDI. The immunoreactivity of substance P (SP) and calcitonin gene-related peptide (CGRP) in the nerve terminals in the nasal mucosa was increased after intranasal application of TDI. We also observed a decrease in the immunoreactivity of SP and CGRP, and an increase in their mRNA expression in trigeminal ganglion neurons. These findings indicate that exposure to TDI enhanced the biosynthesis of both SP and CGRP in the trigeminal ganglion neurons and their axonal transportation to the terminals in the nasal mucosa. In animals pretreated with capsaicin before sensitization, TDI did not induce nasal allergy-like behavior and histamine release in the nasal mucosa. Since capsaicin depletes SP and CGRP in the sensory nerves, this finding indicates neuropeptide-mediated histamine release in the nasal mucosa. All these findings suggest that, on exposure to TDI, the antidromic release of SP and CGRP in the nasal mucosa triggers the release of histamine, resulting in the development of symptom of nasal hyperreactivity.
Takeda
N
N
Department of Otolayngology, Osaka University Medical School, Japan.
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology*; D006168:Guinea Pigs; D008297:Male; D009411:Nerve Endings / Q000737:chemistry; D006255:Rhinitis, Allergic, Seasonal / Q000503:physiopathology*; D012223:Rhinitis, Vasomotor / Q000503:physiopathology*; D013373:Substance P / Q000502:physiology*; D014051:Toluene 2,4-Diisocyanate
D014051:Toluene 2,4-Diisocyanate; D013373:Substance P; D015740:Calcitonin Gene-Related Peptide